HIV Frontline : no.36(1999:Feb.)
| dc.contributor.author | Ferri, Richard S. | |
| dc.contributor.author | Fontaine, Michele | |
| dc.contributor.author | Gallego, Susan M. | |
| dc.contributor.author | Lynch, Vincent J. | |
| dc.contributor.author | O'Brien, John G. | |
| dc.contributor.author | Perez, George | |
| dc.contributor.author | Sheran, Michael E. | |
| dc.contributor.author | Shiloh-Cryer, Angela | |
| dc.contributor.author | Zevin, Barry | |
| dc.contributor.other | World Health CME | |
| dc.date.accessioned | 2025-05-01T15:03:06Z | |
| dc.date.available | 2025-05-01T15:03:06Z | |
| dc.date.issued | 1999 | |
| dc.description.scopeandcontents | HIV Frontline is "a newsletter for professionals who counsel people living with HIV." The February 1999 issue examines the intersection of HIV and addiction, with a focus on addressing the unique challenges faced by injection drug users (IDUs). It highlights the prevalence of co-occurring psychiatric disorders, medical complications such as hepatitis and tuberculosis, and barriers to accessing care. The issue explores models of care, including harm reduction and abstinence-based approaches, emphasizing the importance of compassionate and individualized treatment plans. It also discusses the impact of addiction on adherence to antiretroviral therapy (ART) and strategies to optimize treatment. The publication includes a detailed focus on hepatitis types A, B, and C, addressing their transmission, prevention, and treatment within the context of HIV care. | |
| dc.identifier.uri | https://hdl.handle.net/11244/341107 | |
| dc.relation.ispartofseries | HIV Frontline | |
| dc.rights | Contact UCO Chambers Library's Digital Initiatives Working Group at diwg@uco.edu for the permission policy on the use, reproduction or distribution of this material. | |
| dc.subject.homoit | HIV/AIDS | |
| dc.subject.homoit | Substance use | |
| dc.subject.homoit | Harm reduction | |
| dc.subject.homoit | Antiretroviral drugs | |
| dc.subject.homoit | Hepatitis | |
| dc.subject.homoit | HIV co-infections | |
| dc.subject.homoit | Public health | |
| dc.subject.homoit | HIV counseling | |
| dc.subject.homoit | Mental health | |
| dc.subject.homoit | Injection drug use | |
| dc.subject.keywords | HIV treatment | |
| dc.subject.keywords | Addiction | |
| dc.subject.keywords | Injection drug use | |
| dc.subject.keywords | IDUs | |
| dc.subject.keywords | Antiretroviral therapy | |
| dc.subject.keywords | ART | |
| dc.subject.keywords | Harm reduction | |
| dc.subject.keywords | Abstinence | |
| dc.subject.keywords | Psychiatric disorders | |
| dc.subject.keywords | Hepatitis | |
| dc.subject.keywords | Tuberculosis | |
| dc.subject.keywords | Public health | |
| dc.subject.keywords | Compassionate care | |
| dc.subject.keywords | Substance use | |
| dc.subject.keywords | Co-infection | |
| dc.subject.keywords | Viral hepatitis | |
| dc.subject.keywords | HIV advocacy | |
| dc.subject.keywords | Healthcare barriers | |
| dc.title | HIV Frontline : no.36(1999:Feb.) | |
| dc.type | Periodical |